Abstract.
Whooping cough, or Pertussis, caused by infection by Bordetella pertussis, was once a major 
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It is thus of great concern that Pertussis appears resurgent in numerous countries despite high 33 levels of vaccination. There is a strong link between the use of ACVs and resurgence, which has 34 raised a number of important questions regarding vaccine efficacy and the ability of these vaccines 35 to continue to control disease at the population level (Burns, et al. 2014 : S32-S5). This is not only 36 of concern to the developed countries using these vaccines, but world-wide as many other coun-37 tries aspire to switch to ACVs due to their perceived better safety profile compared to WCV.
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ACVs comprise purified B. pertussis proteins, most contain filamentous haemagglutinin, pertussis 40 toxin and pertactin while some also include fimbrial proteins (Fim2 and Fim3). ACVs were devel-41 oped in response to concerns over reactions to vaccination with WCV. Injection site soreness, irri-42 tability and low grade fever were common sequelae while a syndrome termed Pertussis-vaccine 43 encephalopathy was an association between WCV and serious neurological episodes (Cherry 
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ACVs are considered much better tolerated (Cherry 1993 : 21-4).
48
However, it has been long-recognised that WCV and ACV induce immunity of different profiles 49 even though clinical trials of ACVs established that they are as efficacious as WCV for the prime 50 consideration of protecting young babies and infants from classic Pertussis disease, for example 51 (Lugauer, et al. 2002: 142-6 ). However, it is now becoming evident that there are important differ- 
54
These studies found a strong correlation between the use of ACV and a higher risk of infection in 55 older children and adolescents.
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Also there are clear differences between the T cell responses induced by WCV compared to ACV, 58 being Th1/Th17-biased compared to Th2/Th17 biased respectively (Ross, et al. 2013: e1003264) .
59
The consequences of differences between ACV and WCV induced immunity have become clearer 60 in a recent study in the recently developed infant baboon model of infection. This demonstrated 61 that ACVs protect the individual from manifestations of serious disease but not from colonisation 62 and that ACV-vaccinated, colonised baboons are able to transmit bacteria to naive animals 63 (Warfel, et al. 2013 ). The strongest resistance to challenge with B. pertussis was observed for 64 convalescent animals while baboons vaccinated with WCV became colonised but to a lower ex-65 tent, and for a shorter period of time, than ACV vaccinated animals. The same skew in T cell re-66 sponses to ACV were observed in baboons.
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Overall, there are clear differences in the type of immunity that ACVs induce compared to WCV, 
72
These data strongly suggest that the switch from WCV to ACV will have caused changes to the 73 epidemiology of Pertussis in regions using ACV. Thus, it is likely that this has at least played a part 74 in, if not caused, the resurgence of Pertussis experienced by many of these countries.
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It is plausible that a change in host immunity and overall epidemiology will have an effect on the B. 
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infection biology has many critical knowledge gaps that will need to be filled to meet these aims.
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Much of our knowledge of B. pertussis virulence is based on a relatively small number of B. per-87 tussis proteins. The advance of functional genomics means it is now feasible to study B. pertussis 88 at a systems level, using genome-wide approaches that are unbiased compared to more traditional 89 studies of individual proteins or genetic loci. Here we discuss the contribution of genomics anal-90 yses to the current picture of B. pertussis adaptation, and how they might address the important 91 questions arising during debate of resurgence.
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B. pertussis phylogeny in the pre-genomics era.
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The study of B. pertussis phylogeny in the pre-genomics era was hampered by the very low levels 
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The ptxP3 allele has received particular attention. The SNP giving rise to this allele lies in a binding 
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Such studies revealed that new alleles or sequence types arose over time and often one allele ap- 
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However, the focus on very limited regions of the genome, in a bacterium with relatively low levels 155 of mutation, meant that there was insufficient ability to discriminate between strains co-circulating 156 in most populations to reveal the true picture of strain diversity of B. pertussis.
158 159
Genomic analysis.
160
Genomics has been hugely informative to the study of Bordetella, B. pertussis in particular. The 
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tive studies of these three Bordetella will yield a fresh insight into the evolution of whooping cough.
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The availability of a reference B. pertussis genome sequence allowed further interrogation of B. 
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More recently, next generation sequencing has provided a quantum leap in analysis of B. pertussis 223 enabling whole genome sequences to be generated for multiple strains, and for them to be re- 
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This seminal study included strains isolated during and subsequent to the introduction of ACVs but 256 only 3 isolates were more recent than 2008. A more recent study built on these observations,
257
again utilising whole genome sequencing but with a focus on strains isolated during the UK 2012
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Pertussis outbreak (Sealey, et al. 2014 ). This revealed that this large outbreak was polyclonal in 
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The genome sequences generated in these studies allowed calculation of SNP densities for differ- 
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ing genes is significantly higher among strains isolated since the introduction of ACVs compared to 276 those isolated prior to this (Sealey, et al. 2014) . This is consistent with the ACV antigen encoding 277 genes being under selection pressure prior to vaccination. These proteins are highly immunogenic
278
(hence being selected for vaccination) and infection would generate immunity directed against 279 them. However, there is a clear signal that their rate of evolution has increased recently, and this
280
could be due to ACV-induced immunity focusing on these few proteins. This raises obvious con-
281
cerns about accelerated evolution of B. pertussis and the effect of this on the ability of ACV to con-
282
trol Pertussis.
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These studies represent a step change in the analysis of 
290
the data raise as many questions as they answer, and answering these questions is going to be 291 critical to understanding the current picture of resurgence and perhaps more importantly, the likely 292 trajectory of Pertussis incidence in future years.
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For example, if vaccination creates selection pressure on ACV antigen genes, why is greater varia-
295
tion not observed? Although genomic analyses have identified changes in vaccine antigen gene 296 alleles over time, and shown that these genes are faster evolving than other surface protein encod-
297
ing genes, the level of variation appears to be still very low.
299
For ptxA, just eight alleles were observed world wide, including two silent mutations and thus just 300 six putative protein variants are known, with just one or two amino acid differences between them.
301
Furthermore, ptxA1 and ptxA2 were found in 96% of the strains (Bart, et al. 2013 
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Thus, there appears to be striking differences between antigens in the effects of any ACV- 
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In particular, B. pertussis appears to be restricted to a single niche, the human nasopharynx. Many 
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Genome arrangement affects several factors thought to be determinants of gene expression (for 
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The difficulty will be devising approaches to investigate diversity among strains. Many of the de- 
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Clearly it is very important to decipher the precise mechanisms of immunity arising from infection 
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However, it is crucial that collection of B. pertussis cultures is continued in order to be able to 492 monitor the pathogen, detect further changes in it and for studies that investigate the effects of any 493 changes.
495
The resurgence of Pertussis has given renewed impetus to the need to better understand B. per- 
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The resurgence of Pertussis in countries using the ACV has raised serious public health concerns. 
